Home›Stock Screener›Vivo Bio Tech›Intrinsic Value

Vivo Bio Tech Intrinsic Value

Vivo Bio Tech intrinsic value. Vivo Bio Tech (VIVOBIOT) median intrinsic value is ₹35.80 from 8 valuation models (range ₹13–₹43), vs current price ₹14.32 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Browse Vivo Bio Tech financial data for revenue, profit, balance sheet and cash flow data.

Market Price (CMP)
₹14.32
Primary Intrinsic Value
₹42.96
Market Cap
₹31.5 Cr
+150.0% Upside
Median Value
₹35.80
Value Range
₹13 - ₹43
Assessment
Trading Below Calculated Value
Safety Margin
60.0%

VIVOBIOT Valuation Methods Summary — DCF, Graham Number & P/E

Vivo Bio Tech intrinsic value across 8 models vs current price ₹14.32 — upside/downside and value range per method. For current market price and key ratios, visit Vivo Bio Tech share price chart.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹42.96 ₹34.37 - ₹51.55 +200.0% EPS: ₹2.00, Sector P/E: 22x
Book Value Method asset ₹35.80 ₹32.22 - ₹39.38 +150.0% Book Value/Share: ₹42.27, P/B: 2.0x
Revenue Multiple Method revenue ₹28.64 ₹25.78 - ₹31.50 +100.0% Revenue/Share: ₹34.55, P/S: 2.0x
EBITDA Multiple Method earnings ₹28.64 ₹25.78 - ₹31.50 +100.0% EBITDA: ₹32.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹35.80 ₹28.64 - ₹42.96 +150.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹12.80 ₹11.52 - ₹14.08 -10.6% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹30.90 ₹27.81 - ₹33.99 +115.8% Revenue Growth: 6.0%, Adj P/E: 15.5x
Graham Defensive Method conservative ₹42.96 ₹38.66 - ₹47.26 +200.0% EPS: ₹2.00, BVPS: ₹42.27
Method Types: Earnings Asset DCF Growth Dividend Conservative

VIVOBIOT Intrinsic Value vs Market Price — All Valuation Models

Vivo Bio Tech fair value range ₹13–₹43 vs current market price ₹14.32 across 8 valuation models. Analyse Vivo Bio Tech shareholding analysis to track promoter, FII and institutional holdings.

VIVOBIOT Intrinsic Value Analysis — Undervalued or Overvalued?

Vivo Bio Tech median intrinsic value ₹35.80, current price ₹14.32 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.

What is the intrinsic value of VIVOBIOT?

Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Vivo Bio Tech (VIVOBIOT) is ₹35.80 (median value). With the current market price of ₹14.32, this represents a +150.0% variance from our estimated fair value.

The valuation range spans from ₹12.80 to ₹42.96, indicating ₹12.80 - ₹42.96.

Is VIVOBIOT undervalued or overvalued?

Based on our multi-method analysis, Vivo Bio Tech (VIVOBIOT) appears to be trading below calculated value by approximately 150.0%.

VIVOBIOT Financial Health — Key Ratios vs Industry Benchmarks

Vivo Bio Tech financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 4.3% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 35.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.43x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

VIVOBIOT Cash Flow Quality — Operating & Free Cash Flow

Vivo Bio Tech operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹35 Cr ₹6 Cr Positive Free Cash Flow 7/10
March 2025 ₹12 Cr ₹4 Cr Positive Free Cash Flow 7/10
March 2024 ₹16 Cr ₹12 Cr Positive Free Cash Flow 8/10
March 2023 ₹15 Cr ₹13 Cr Positive Free Cash Flow 8/10
March 2022 ₹17 Cr ₹-9 Cr Positive Operating Cash Flow 6/10